BML Capital Management, LLC
CIK
1616824
Location
ZIONSVILLE, IN
Portfolio Value
Small
$155,478,198
Diversification
Moderately concentrated
Filing Date
Global Rank
#4,423
/ 8,232
▲ 964
Top Industry
Biotechnology
80.8%
3Y Alpha vs SPY
+35.5%
Period ended 2 months ago
Filed May 6, 2026 · 39d
14 quarters · since Dec 2022
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+281.9%
SPY
+76.3%
Annualised alpha
+35.5%
Max drawdown
−46.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
16 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
34.4%
−3.4 pts
Top 5
76.0%
−5.3 pts
Top 10
94.2%
−3.1 pts
HHI
1,954
Moderately concentrated−227
Portfolio Trend
14 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 85.5% | $132,927,915 |
| Consumer Cyclical | 9.7% | $15,152,400 |
| Consumer Defensive | 4.8% | $7,397,883 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | −431,343 | 7,058,657 | $37,975,574 | |
| No positions match the current search. | |||||
16 positions ·
$155,478,198 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Held | 14,250,000 | $53,437,500 | 34.37% | |
| AVIR |
Atea Pharmaceuticals, Inc.
Healthcare
|
Reduced | 7,058,657 | $37,975,574 | 24.43% | |
| ORMP |
Oramed Pharmaceuticals Inc.
Healthcare
|
Held | 3,167,231 | $10,768,585 | 6.93% | |
| TLYS |
Tilly's, Inc.
Consumer Cyclical
|
NEW | 2,150,000 | $8,707,500 | 5.60% | |
| OM |
Outset Medical, Inc.
Healthcare
|
Added | 1,902,201 | $7,304,451 | 4.70% | |
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Added | 5,320,000 | $6,596,800 | 4.24% | |
| KMX |
Carmax Inc
Consumer Cyclical
|
Held | 155,000 | $6,444,900 | 4.15% | |
| KZR |
Kezar Life Sciences, Inc.
Healthcare
|
Held | 720,787 | $5,348,239 | 3.44% | |
| TIL |
Instil Bio, Inc.
Healthcare
|
Held | 645,600 | $5,319,744 | 3.42% | |
| TGT |
Target Corp
Consumer Defensive
|
Held | 37,500 | $4,545,000 | 2.92% | |
| KHC |
Kraft Heinz Co
Consumer Defensive
|
NEW | 125,000 | $2,811,250 | 1.81% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
NEW | 154,961 | $2,153,957 | 1.39% | |
| PLRX |
Pliant Therapeutics, Inc.
Healthcare
|
Held | 1,546,137 | $1,948,132 | 1.25% | |
| CNTB |
Connect Biopharma Holdings Ltd
Healthcare
|
Held | 408,887 | $1,071,283 | 0.69% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
Added | 200,730 | $1,003,650 | 0.65% | |
| WMT |
Walmart Inc.
Consumer Defensive
|
Held | 335 | $41,633 | 0.03% |